Microvascular Tissue for Leg Defect in the Course of Sarcoma Microvascular Tissue for Leg Defect in the Course of Sarcoma
This case report describes the use of processed microvascular tissue for the treatment of a complicated left leg wound in a sarcoma patient undergoing chemotherapy.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2023 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
Peter Meyer, Manager and Former William Morris Agent, Dies at 68
Peter Meyer, who represented the likes of Tom Hanks, James Caan and William Shatner as a talent agent at William Morris before spending the past three decades leading his own management firm, has died. He was 68. Meter died May 14 in his Los Angeles home after a five-year battle with sarcoma, his…#petermeyer #tomhanks #jamescaan #williamshatner #williammorris #patriciakmeyer #womenofbrewsterplace #chrismeyer #caa #wma (Source: Reuters: Health)
Source: Reuters: Health - June 6, 2023 Category: Consumer Health News Source Type: news
Doctors missed teenager's terminal cancer - and told her to try mindfulness
Olivia Maunder, 15, of Bordon, Hampshire, was diagnosed with Ewing Sarcoma - a rare form of the disease affecting the bones and surrounding tissue - and now has just months to live. (Source: the Mail online | Health)
Source: the Mail online | Health - May 31, 2023 Category: Consumer Health News Source Type: news
AI may help diagnose cardiac amyloidosis on whole-body scintigraphy
An artificial intelligence (AI) model trained on whole-body scintigraphy image...Read more on AuntMinnie.comRelated Reading:
PET/CT bests bone scintigraphy for detecting invasive breast cancer
PSMA-PET shows value in primary staging of prostate cancer
Fast acquisition techniques cut SPECT/CT bone scan times by half
AI can detect metastatic bone lesions on scintigraphy
PET recommended over bone scintigraphy in pediatric sarcoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2023 Category: Radiology Source Type: news
Roswell Park sued by former oncologist for gender discrimination and retaliation
Dr. Anne Grand ’Maison, an oncologist who worked in the sarcoma clinic, said she was fired after reporting patient safety failures. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - February 21, 2023 Category: Health Management Authors: Tracey Drury Source Type: news
What Causes Mediastinal Masses?
Discussion
The mediastinum resides in the chest and is the space bounded by the thoracic inlet cephalically, diaphragm caudally, sternum anteriorly and transverse process of the spine posteriorly, and mediastinal pleura and lungs laterally. It is divided into various compartments:
Superior mediastinum
Bounded by the thoracic inlet cephalically and a horizontal plane passing from the manubriosternal joint to the junction of T4/T5 vertebrae horizontally.
Structures include: esophagus, trachea, parts of great vessels and first branches, great veins and initial branches, thymus, vagus, phrenic and other nerves, thoracic duct...
Source: PediatricEducation.org - February 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
High-Intensity MRI Can ID Local Recurrence for Musculoskeletal STS
WEDNESDAY, Feb. 8, 2023 -- Magnetic resonance imaging (MRI) used at high intensity can detect clinically occult local recurrences (LRs) for musculoskeletal soft-tissue sarcoma (STS), according to a systematic review published online Jan. 26 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 8, 2023 Category: Pharmaceuticals Source Type: news
Scientists pinpoint protein that helps cancer-causing viruses evade immune response
The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers. For the first time, UNC School of Medicine scientists have discovered that these viruses use a human protein called barrier-to-autointegration factor 1, or BAF, to evade our innate immune response, allowing the viruses to spread and cause disease. (Source: World Pharma News)
Source: World Pharma News - February 6, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development ROOT Source Type: news
MRI shows promise for tracking recurrence of soft-tissue sarcoma
MRI shows promise as an effective way to identify recurrence of musculoskeleta...Read more on AuntMinnie.comRelated Reading:
Deep learning: A new frontier for musculoskeletal MRI
MRI shows negative impact of racket sports
Gadolinium MRI improves diagnosis of shoulder condition
SNMMI: AI can predict survival in sarcoma patients
MRI, ultrasound combined best assess baseball elbow pain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 3, 2023 Category: Radiology Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news
Can the field of radiobiology survive?
Unless it attracts new students, the profession of radiobiology in the U.S...Read more on AuntMinnie.comRelated Reading:
ACR, ASTRO cry foul over imaging cuts in 2023 Omnibus bill
ASRT bestows $25K research grant
Shorter regimen in sarcoma care could widen access to treatment
ASTRO: Therapy combo may slow growth of prostate cancer
ASTRO: Radiation therapy boosts survival rate from liver cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 1, 2023 Category: Radiology Source Type: news
Genetic Clues to'Devastating' Sarcoma Diagnosis Uncovered Genetic Clues to'Devastating' Sarcoma Diagnosis Uncovered
Variants in two gene pathways appear to be directly linked to sarcoma development. The finding offers hope for earlier cancer detection and treatment, suggest researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Drug Approved to Help Young Patients Battle a Rare Cancer
TUESDAY, Jan. 3, 2023 -- The U.S. Food and Drug Administration has approved the immunotherapy drug Tecentriq (atezolizumab) for use in patients with unresectable or metastatic alveolar soft part sarcoma (ASPS). The approval was granted following the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 3, 2023 Category: General Medicine Source Type: news
Tecentriq Approved to Help Young Patients Battle Metastatic Alveolar Soft Part Sarcoma (ASPS)
TUESDAY, Jan. 3, 2023 -- The U.S. Food and Drug Administration has approved the immunotherapy drug Tecentriq (atezolizumab) for use in patients with unresectable or metastatic alveolar soft part sarcoma (ASPS). The approval was granted following the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 3, 2023 Category: General Medicine Source Type: news
